Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism Receiving Edoxaban in the Real World-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism Receiving Edoxaban in the Real World

Published:2023-12-23 Issue: Volume: Page:
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Yamashita Yugo¹,Fukasawa Toshiki²,Takeda Chikashi³,Takeuchi Masato³,Ono Koh¹,Kawakami Koji³

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University

2. Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University

3. Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-23-0818/_pdf

Reference34 articles.

1. 1. Di Nisio M, van Es N, Buller HR. Deep vein thrombosis and pulmonary embolism. Lancet 2016; 388: 3060–3073, doi:10.1016/S0140-6736(16)30514-1.

2. 2. Kyrle PA, Rosendaal FR, Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet 2010; 376: 2032–2039, doi:10.1016/S0140-6736(10)60962-2.

3. 3. Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, et al. Antithrombotic therapy for VTE disease: Second update of the CHEST guideline and expert panel report. Chest 2021; 160: e545–e608, doi:10.1016/j.chest.2021.07.055.

4. 4. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41: 543–603, doi:10.1093/eurheartj/ehz405.

5. 5. Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: Optimal management of anticoagulation therapy. Blood Adv 2018; 2: 3257–3291, doi:10.1182/bloodadvances.2018024893.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arg-Specific serine Protease-Targeted edoxaban tosylate monohydrate-Poly (lactic-co-glycolic acid) Nanoparticles: Investigating Stuart-Prower factor targeting and intestinal distribution through Ex-Vivo fluorescent visualization;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

2. Edoxaban enfolded beta-1,4-poly- d -glucosamine nanoparticles for targeting eponym Stuart–Prower factor for treatment of venous thrombosis;Journal of Drug Targeting;2024-07-22

3. Unapproved Dose of Direct Oral Anticoagulants for Venous Thromboembolism　― Right or Wrong? ―;Circulation Journal;2024-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3